Cargando…

Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro

Schwann cells (SCs) have been reported as a possible source of neurotrophic support for spiral ganglion neurons (SGNs). This study was aimed to investigate whether S100A4 was contributed in the functional effects of SCs on SGNs. SCs were transfected with S100A4 vector or small interfering RNA (siRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Li, Tang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553331/
https://www.ncbi.nlm.nih.gov/pubmed/27669149
http://dx.doi.org/10.1080/21655979.2016.1238534
_version_ 1783256605840637952
author Lei, Li
Tang, Li
author_facet Lei, Li
Tang, Li
author_sort Lei, Li
collection PubMed
description Schwann cells (SCs) have been reported as a possible source of neurotrophic support for spiral ganglion neurons (SGNs). This study was aimed to investigate whether S100A4 was contributed in the functional effects of SCs on SGNs. SCs were transfected with S100A4 vector or small interfering RNA (siRNA) against S100A4, and the transfection efficiency was verified by quantitative PCR (qPCR) and Western blot. The migration of transfected SCs was determined by Transwell assay, and the expression levels of vascular endothelial growth factor precursor (VEGF) and matrix metallopeptidase 9 (MMP-9) were measured by Western blot. Co-culture of either S100A4 overexpressed or suppressed SCs with SGNs, and the growth associated protein 43 (GAP43) expression in SGNs was detected by immunofluorescence (IF), qPCR and Western blot. The migration of SCs was significantly enhanced by S100A4 overexpression (P < 0.001), while was suppressed by S100A4 knockdown (P < 0.01). Further, the expressions of VEGF and MMP-9 were notably up-regulated by S100A4 overexpression, while were down-regulated by S100A4 knockdown. Moreover, co-culture with the S100A4 overexpressed SCs significantly increased the expression of GAP43 in SGNs (P < 0.01). As expected, co-culture with S100A4 knockdown SCs decreased GAP43 level (P < 0.05). S100A4 enhanced the migratory ability of SCs. SCs genetically modified to overexpress the S100A4 could up-regulate the GAP43 expression in SGNs.
format Online
Article
Text
id pubmed-5553331
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-55533312017-09-26 Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro Lei, Li Tang, Li Bioengineered Research Paper Schwann cells (SCs) have been reported as a possible source of neurotrophic support for spiral ganglion neurons (SGNs). This study was aimed to investigate whether S100A4 was contributed in the functional effects of SCs on SGNs. SCs were transfected with S100A4 vector or small interfering RNA (siRNA) against S100A4, and the transfection efficiency was verified by quantitative PCR (qPCR) and Western blot. The migration of transfected SCs was determined by Transwell assay, and the expression levels of vascular endothelial growth factor precursor (VEGF) and matrix metallopeptidase 9 (MMP-9) were measured by Western blot. Co-culture of either S100A4 overexpressed or suppressed SCs with SGNs, and the growth associated protein 43 (GAP43) expression in SGNs was detected by immunofluorescence (IF), qPCR and Western blot. The migration of SCs was significantly enhanced by S100A4 overexpression (P < 0.001), while was suppressed by S100A4 knockdown (P < 0.01). Further, the expressions of VEGF and MMP-9 were notably up-regulated by S100A4 overexpression, while were down-regulated by S100A4 knockdown. Moreover, co-culture with the S100A4 overexpressed SCs significantly increased the expression of GAP43 in SGNs (P < 0.01). As expected, co-culture with S100A4 knockdown SCs decreased GAP43 level (P < 0.05). S100A4 enhanced the migratory ability of SCs. SCs genetically modified to overexpress the S100A4 could up-regulate the GAP43 expression in SGNs. Taylor & Francis 2016-09-26 /pmc/articles/PMC5553331/ /pubmed/27669149 http://dx.doi.org/10.1080/21655979.2016.1238534 Text en © 2017 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Research Paper
Lei, Li
Tang, Li
Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro
title Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro
title_full Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro
title_fullStr Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro
title_full_unstemmed Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro
title_short Schwann cells genetically modified to express S100A4 increases GAP43 expression in spiral ganglion neurons in vitro
title_sort schwann cells genetically modified to express s100a4 increases gap43 expression in spiral ganglion neurons in vitro
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553331/
https://www.ncbi.nlm.nih.gov/pubmed/27669149
http://dx.doi.org/10.1080/21655979.2016.1238534
work_keys_str_mv AT leili schwanncellsgeneticallymodifiedtoexpresss100a4increasesgap43expressioninspiralganglionneuronsinvitro
AT tangli schwanncellsgeneticallymodifiedtoexpresss100a4increasesgap43expressioninspiralganglionneuronsinvitro